News articles about SeaSpine Holdings Corporation (NASDAQ:SPNE) have been trending somewhat positive on Tuesday, according to Accern Sentiment Analysis. The research firm rates the sentiment of news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. SeaSpine Holdings Corporation earned a media sentiment score of 0.23 on Accern’s scale. Accern also assigned media headlines about the medical equipment provider an impact score of 45.5552242512597 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Here are some of the news stories that may have impacted Accern Sentiment’s analysis:

SPNE has been the subject of several recent research reports. HC Wainwright set a $15.00 price target on SeaSpine Holdings Corporation and gave the company a “buy” rating in a report on Monday, August 7th. Piper Jaffray Companies restated a “buy” rating and set a $22.00 target price on shares of SeaSpine Holdings Corporation in a research note on Sunday, August 20th. Zacks Investment Research upgraded SeaSpine Holdings Corporation from a “hold” rating to a “buy” rating and set a $13.00 target price for the company in a research note on Tuesday, September 12th. Finally, BTIG Research restated a “buy” rating on shares of SeaSpine Holdings Corporation in a research note on Monday, November 6th. One research analyst has rated the stock with a sell rating and four have issued a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $16.33.

SeaSpine Holdings Corporation (NASDAQ:SPNE) opened at $9.80 on Tuesday. SeaSpine Holdings Corporation has a twelve month low of $6.31 and a twelve month high of $13.46.

COPYRIGHT VIOLATION WARNING: This article was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this article can be accessed at https://www.thecerbatgem.com/2017/11/14/seaspine-holdings-corporation-spne-given-coverage-optimism-rating-of-0-23.html.

About SeaSpine Holdings Corporation

SeaSpine Holdings Corporation is a medical technology company. The Company is focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company operates through the development, manufacture and marketing of orthobiologics and spinal fusion hardware segment.

Insider Buying and Selling by Quarter for SeaSpine Holdings Corporation (NASDAQ:SPNE)

Receive News & Stock Ratings for SeaSpine Holdings Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaSpine Holdings Corporation and related stocks with our FREE daily email newsletter.